Akuru Pharma was one of twelve finalists selected by an expert jury to pitch their idea at this years Startup Challenge at the Nordic Life Science Days in Stockholm 10-12 september. Akuru Pharmas pitch, held by the company’s CEO, came in at the second place in the competition!
Akuru Pharma has been granted a total of 600,000 SEK from Sten K Johnsons Foundation and from Vinnova’s Runner up SME Instruments. Most of the sum comes from Vinnova, which handles the European Commission’s call for proposals for Horizon2020 SME instrument. This funding will be used partly to advance the company’s plan for diagnostic and[…]
Akuru Pharma is since june 2017 a member of SmiLe Incubator, an incubator that helps life science entrepreneurs commercialize their business ideas and is located at Medicon Village in Lund. www.smileincubator.life
Article about Akuru Pharma’s research in Lund University Research Magazine http://www.researchmagazine.lu.se/2017/01/11/quicker-diagnosis-of-renal-cancer/
Almi Invest recently made a pre-investment in Akuru Pharma to support the development of diagnostic tools for detection of kidney cancer
Akuru Pharma AB was recently granted “Acceleratorstöd” from Innovationskontor Syd for development of novel diagnostic tools for kidney cancer.